← All diseases Cancer

Liver cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the most robust evidence (78)Meta-analysis (34)Treatment guideline (5)Systematic review (18)Randomized trial (14)Phase 3 study (7)Clinical trial (607)Review article (441)Early study (phase 1 or 2) (23)Laboratory or animal study (163)Case description (106)Commentary or editorial (68)Retracted publication (8)Concerns have been raised (1) Only studies currently recruiting participants (36)

Filter

Publications and studies (3338)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment strategies and prospects for hepatic fibrosis: Application of traditional Chinese medicine polysaccharides in modulating of the TGF-β1/Smad pathway. (2026/11/15) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Gut bacteria inhibited liver tumor growth during Rheum officinale Baill. treatment in mice. (2026/11/15) ♡
• Deterministic and probabilistic risk assessment of aflatoxins and zearalenone in processed maize products marketed in Türkiye. (2026/11/01) ♡
• PTPN14 functions as an oncogenic promoter in colon adenocarcinoma and liver hepatocellular carcinoma via Notch Signaling. (2026/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Chinese medicine reverses immune checkpoint resistance through lactate metabolic reprogramming in hepatocellular carcinoma: Mechanisms and therapeutic implications. (2026/10/28) ♡
• Interface-enhanced label-free FeOOH-mesoporous TiO(2) nanocomposite biosensor for highly sensitive quantitative exosome detection to assist cancer screening. (2026/10/08) ♡
• Pyridyl ethyl diazoacetate derivatization enables LC-MS annotation of cholesterol and its metabolites. (2026/10/08) ♡
• Huaier counteracts sorafenib resistance in hepatocellular carcinoma by activating NCOA4-mediated ferritinophagy to induce ferroptosis via modulation of iron and lipid metabolism. (2026/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review). (2026/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms of Wu Zhuyu Decoction in the treatment of hepatocellular carcinoma: An integrative review of ethnopharmacology, pharmacological actions, and clinical potential. (2026/09/15) ♡
• Genetic Adaptation to Tibetan High Altitude and Hepatocellular Cancer Risk: Integrative Bidirectional Mendelian Randomization and Single-Cell RNA Sequencing Analysis. (2026/09/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Role of Magnetic Resonance Elastography in the Assessment of Liver Fibrosis: A Descriptive Study. (2026/09/01) ♡
• The decade that changed hepatocellular carcinoma: shaping a new treatment paradigm. (2026/09/01) ♡
• Jianpi Huayu decoction alleviates hepatic fibrosis involving coordinated modulation of PPARα-mediated lipid metabolic reprogramming and the ROCK pathway. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Protective effects of Astragaloside IV on various liver diseases: From chemistry to herbal medicines (Review). (2026/09/01) ♡
• The Impact of Chronic Hepatitis D Virus Infection on Health-Related Quality of Life and Fatigue: A Real-World International Study. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Breaking Barriers in Hepatocellular Carcinoma: Synergistic Potential of Stereotactic Body Radiotherapy Combined With Immunotherapy. (2026/09/01) ♡
• Noncoding RNA Transcripts Based Molecular Phenotyping of MASLD and MASH Patients. (2026/09/01) ♡
• ATP13A2 Promotes Endothelial Angiogenic Phenotypes and Is Associated With Poor Prognosis in Liver Hepatocellular Carcinoma. (2026/08/10) ♡
• Photo-Generated (1)O(2) Triggers In Situ RNA Crosslinking for High-Contrast Tumor MRI and Effective Tumor Suppression. (2026/08/10) ♡
• Retraction Note: Euphorbia helioscopia L. extract suppresses hepatitis B virus-related hepatocellular carcinoma via alpha serine/threonine-protein kinase and Caspase-3. (2026/08/10) ♡
• Lysosome-Targeted Self-Adjuvanting Ammonia Nanogenerator Potentiates Hepatocellular Carcinoma Immunotherapy via Ammonia Death. (2026/08/09) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter: Calendar Era or Antiviral Choice-What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? (2026/08/09) ♡
• Myeloperoxidase/ASGPR Dual-Targeting Self-Amplifying Nanoplatform for Synergistic Anti-Metastatic Therapy of Hepatocellular Carcinoma. (2026/08/08) ♡
• Plectin-mediated mitochondrial fusion is necessary for hepatocellular carcinoma cell migration promoted by higher matrix stiffness. (2026/08/08) ♡
• Integrative 3D genome and epigenomic analysis identifies TP53RK and SYBU as critical regulators of stemness and anti-tumor immunity in HCC. (2026/08/08) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Author's reply: ``Survival fragility in advanced hepatocellular carcinoma immunotherapy trials requires clinical context''. (2026/08/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in stimuli-responsive hydrogels for liver disease therapy: mechanisms, applications, and translational perspectives. (2026/08/08) ♡
• HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy. (2026/08/08) ♡
• Retraction Note: The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α(2)M. (2026/08/08) ♡
• Inter-Reader Agreement for CT and MRI LI-RADS Version 2018: An Individual Participant Data Meta-Analysis. (2026/08/07) ♡
• Effects of laparoscopic splenectomy and azygoportal disconnection on liver reserve function for cirrhosis patients: a 1-year prospective study. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies. (2026/08/07) ♡
• (99m)Technetium SPECT-guided functional liver-sparing radiotherapy planning for recurrent hepatocellular carcinoma: a dosimetric comparison. (2026/08/07) ♡
• METTL3 promotes proliferation and invasion and inhibits ferroptosis in hepatocellular carcinoma by mediating m6A methylation modification of NUPR1. (2026/08/07) ♡
• Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Plant-derived natural products against hepatocellular carcinoma: chemical diversity, mechanisms of action, and organ-based classification. (2026/08/07) ♡
• miR149-5p: A hepatocyte EXOmotif sequence containing microRNA that attenuates liver fibrosis by specifically targeting PDGFRB in HSCs. (2026/08/07) ♡
• Identification of CLIC1 as a direct molecular target of luteolin associated with ferroptosis induction in hepatocellular carcinoma. (2026/08/07) ♡
• Liver cells-derived extracellular vesicles deliver a dual-functional RNA ligand for TACE treatment of hepatocellular carcinoma. (2026/08/07) ♡
• Quercetin, an ingredient of Jiedu Xiaozheng Yin, alleviates hepatocellular carcinoma progression by regulating CYP1A2/PTEN/PI3K/Akt axis. (2026/08/07) ♡
• Dual-Switchable Nanoparticles Resolving the Safety-Efficacy Paradox of Sonodynamic Immunotherapy for Hepatocellular Carcinoma. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The interplay between chronic inflammation and tumorigenesis: unraveling the inflammation-driven axis. (2026/08/07) ♡
• BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma. (2026/08/07) ♡
• Successful Long-Term Survival With Various Modalities of Treatments Combining Minimally Invasive Surgery for Intrahepatic and Extrahepatic Recurrence of Hepatocellular Carcinoma: A Case Report. (2026/08/07) ♡
• Robotic Whole-graft Liver Transplant: Lesson Learned And Outcomes After 45 Cases. (2026/08/06) ♡
• Comparative Evaluation of Adaptive Focused Acoustics- and SP3-Based Workflows for Deep Proteomic Profiling of 30-Year-Old Formalin-Fixed Paraffin-Embedded Tissues. (2026/08/06) ♡
• Non-canonical mTORC1-TFEB activation promotes hepatocyte plasticity and high-grade malignancy in hepatocellular carcinoma. (2026/08/06) ♡
• Sodium Glucose Co-Transporter 2 Inhibitors Use in Diabetic Patients with Cirrhosis Improves Liver-related Outcomes and Survival. (2026/08/06) ♡
• C1R suppresses hepatocellular carcinoma cell aggressiveness through promoting HIF-1α degradation and modulating cuproptosis-related protein expression. (2026/08/06) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.